NASDAQ:ZSAN
Delisted
Zosano Pharma Corp Stock News
$0.110
-0.0088 (-7.40%)
At Close: Sep 27, 2022
ZSAN Stock Price Increased Over 100% This Past Week: Why It Happened
08:00am, Tuesday, 09'th Feb 2021
The stock price of Zosano Pharma Corp (NASDAQ: ZSAN) increased by over 100% this past week. This is why it happened.
Zosano Pharma Presents Early-Onset of Action Data for Qtrypta™ in Acute Treatment of Migraines
08:30am, Monday, 01'st Feb 2021
FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that early onset of action data for Qtrypta™,
Zosano Pharma Requests Type A Meeting with the FDA to Review Resubmission Plans for Qtrypta™ New Drug Application
04:05pm, Monday, 04'th Jan 2021
FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on December 30, 2020 the company requested
Zosano Pharma to Present at the H.C. Wainwright Virtual BioConnect Conference
08:30am, Monday, 04'th Jan 2021
FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer,
LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #ZSAN--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Zosano Pharma Corporation.
New York, New York--(Newsfile Corp. - December 28, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano"
New York, New York--(Newsfile Corp. - December 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between F
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NASDAQ: ZSAN)
New York, New York--(Newsfile Corp. - December 26, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NASDAQ: ZSA
NEW YORK, Dec. 25, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United
New York, New York--(Newsfile Corp. - December 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
NEW YORK, Dec. 24, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13, 2017 an
New York, New York--(Newsfile Corp. - December 24, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NASDAQ: ZSA
New York, New York--(Newsfile Corp. - December 23, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
New York, New York--(Newsfile Corp. - December 23, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between F